NCT00826371View on ClinicalTrials.gov

Evaluation of Safety and Efficacy of Once Monthly Ranibizumab Injections in Chinese Patients With Wet Age Related Macular Degeneration (AMD) Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

July 31, 2010

Conditions
Age Related Macular Degeneration
Interventions
DRUG

ranibizumab 0.5 mg

Trial Locations (6)

100044

Novartis Investigative Site, Beijing

100730

Novartis Investigative Site, Beijing

200031

Novartis Investigative Site, Shanghai

200080

Novartis Investigative Site, Shanghai

510060

Novartis Investigative Site, Guangzhou

610041

Novartis Investigational Site, Chengdu

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY